About the Authors

Brendan D. Galvin

Contributed equally to this work with: Brendan D. Galvin, Zhiru Li

Affiliation New England Biolabs, Division of Genome Biology, Ipswich, Massachusetts, United States of America

Zhiru Li

Contributed equally to this work with: Brendan D. Galvin, Zhiru Li

Affiliation New England Biolabs, Division of Genome Biology, Ipswich, Massachusetts, United States of America

Estelle Villemaine

Affiliation New England Biolabs, Division of Genome Biology, Ipswich, Massachusetts, United States of America

Catherine B. Poole

Affiliation New England Biolabs, Division of Genome Biology, Ipswich, Massachusetts, United States of America

Melissa S. Chapman

Affiliation New England Biolabs, Division of Genome Biology, Ipswich, Massachusetts, United States of America

Michael P. Pollastri

Affiliation Northeastern University, Department of Chemistry and Chemical Biology, Boston, Massachusetts, United States of America

Paul G. Wyatt

Affiliation Drug Discovery Unit, College of Life Sciences, University of Dundee, Dundee, Scotland, United Kingdom

Clotilde K. S. Carlow

carlow@neb.com

Affiliation New England Biolabs, Division of Genome Biology, Ipswich, Massachusetts, United States of America

Competing Interests

BDG, ZL, EV, CBP, MSC and CKSC have read the journal's policy and have the following conflicts: BDG, ZL, EV, CBP, MSC and CKSC are employees of New England Biolabs. The authors' affiliation with the funder does not alter adherence to all the PLOS Neglected Diseases policies on sharing data and materials.

Author Contributions

Conceived and designed the experiments: BDG ZL CBP MPP PGW CKSC. Performed the experiments: BDG ZL EV CBP MSC. Analyzed the data: BDG ZL EV CBP MSC MPP PGW CKSC. Contributed reagents/materials/analysis tools: BDG PGW. Contributed to the writing of the manuscript: BDG ZL CBP MPP PGW CKSC. Obtained permission for use of compounds: PGW.